BSE filing, NSE: IMAGICAA. Summary written from the filing by ALFA Finder's alert engine.
Imagicaaworld Entertainment Ltd: key numbers
- Share price
- ₹41.70
- Market cap
- ₹2,458 Cr
- Revenue (annual)
- ₹373.9 Cr
- Net profit (annual)
- ₹0.64 Cr
- P/E (TTM)
- 176.8×Sector 34.0×
- Promoter holding
- 73.95%-0.07% QoQ
- FII holding
- 0.17%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Imagicaaworld Entertainment Ltd
All →Imagicaaworld Entertainment Annual General Meeting
Imagicaaworld seeks postal ballot approval to sell Hotel Novotel Imagicaa to Juniper Hotels for ₹248 Crore. A special resolution is required for the slump sale under Section 180(1)(a).
- Value
- ₹248.0 Cr
Imagicaaworld Entertainment Merger & Restructuring
Imagicaaworld seeks postal-ballot approval to sell Hotel Novotel Imagicaa on a slump-sale basis under Section 180(1)(a) and SEBI Reg 37A. No sale price is disclosed in the notice.
Imagicaaworld Entertainment Business Update
Imagicaaworld reported Q2 FY27 footfalls of 2.1 lakh, down 6% YoY. Updates include Novotel sale, full warrant conversion, and acquisition of Shanku's Water Park.
Imagicaaworld Entertainment Management Change
Mr. Suresh Bharathwaj has completed his second term as an Independent Director of Imagicaaworld Entertainment Limited, effective October 17, 2026. He ceases all associated committee roles.
Imagicaaworld Entertainment Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Imagicaaworld Entertainment Merger & Restructuring Worth ₹248 Cr
Imagicaaworld Entertainment is selling its Hotel Novotel Imagicaa undertaking to Juniper Hotels for Rs. 248 Crore, subject to shareholder approval.
- Value
- ₹248.0 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.